基于蛋白质组学筛选并验证慢性鼻窦炎伴鼻息肉的治疗靶点
研究对烟台毓璜顶医院69例CRSwNP和39例对照的鼻黏膜组织行DIA蛋白质组学分析,鉴定1850个差异蛋白,筛选出HCK等8个蛋白激酶;qPCR和WB证实CRSwNP中HCK表达高于对照组(P<0.05),小鼠实验显示HCK抑制剂可降低血清IgE、IL-4、IL-5(均P<0.05),作者认为HCK是潜在治疗靶点。
要点
- CRSwNP组与对照组鼻黏膜组织DIA分析鉴定1850个差异蛋白,其中上调760个、下调1090个。
- WGCNA与激酶筛选交集获得HCK、SYK、PDK2、FGR、PRKCB、ROR1、CAMK1及GRK6共8个蛋白激酶。
- qPCR和WB显示CRSwNP鼻组织中HCK表达明显高于对照组(P<0.05)。
核心结论
- HCK抑制剂能够降低CRSwNP小鼠的炎性指标,HCK有望成为CRSwNP的潜在治疗靶点。
研究设计与样本
- 收集2020年6月至2021年12月于烟台毓璜顶医院耳鼻咽喉头颈外科行手术治疗患者的鼻黏膜组织样本,CRSwNP患者69例,对照组39例。
- 对照组为行上颌窦囊肿切除或视神经减压术的患者。
- 采用LC-MS/MS以DIA模式分析组织样本寻找差异表达蛋白,并结合生物信息学工具分析差异蛋白功能。
- 通过qPCR及WB技术明确CRSwNP患者鼻组织HCK表达情况。
- 构建CRSwNP小鼠模型并给予HCK抑制剂干预,用ELISA检测不同实验组小鼠血清IgE、IL-4及IL-5分泌情况。
主要发现
- 与对照组相比,CRSwNP组鼻黏膜组织筛选出差异蛋白1850个,其中上调蛋白760个,下调蛋白1090个。
- 将细胞计数、CT评分等表型数据与组学结果行WGCNA关联分析,选取MEBrown模块的575个蛋白,与从1850个差异蛋白中进一步筛选出的35个激酶取交集,获得8个蛋白激酶:HCK、SYK、PDK2、FGR、PRKCB、ROR1、CAMK1及GRK6。
- qPCR及WB结果表明,CRSwNP鼻组织中HCK的表达明显高于对照组(P<0.05)。
- 动物实验中,CRSwNP组小鼠血清IgE、IL-4及IL-5分泌量较对照组显著升高(P<0.05)。
- 经HCK抑制剂干预后,小鼠血清IgE、IL-4及IL-5分泌量显著降低(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To identify potential therapeutic targets of chronic sinusitis with nasal polyps (CRSwNP) through proteomics screening of and verify its effectiveness experimentally. Methods: The nasal tissue samples were collected from patients undergoing surgical treatment in the Department of Otorhinolaryngology, Head and Neck Surgery in Yuhuangding Hospital of Yantai from June 2010 to December 2021, including 69 patients with CRSwNP and 39 patients in the control group. Tissue samples were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in data-independent acquisition (DIA) mode to find differentially expressed proteins. Bioinformatics tools were employed to analyze the functions of differentially expressed proteins. The expression of hematopoietic cell kinase (HCK) in nasal tissues of patients with CRSwNP was further confirmed by qPCR and western blot. The mouse model of CRSwNP was established and treated with HCK inhibitor. The levels of inflammatory factors IgE, IL-4 and IL-5 in serum of CRSwNP mice, both treated and untreated with HCK inhibitors, were detected by enzyme-linked immunosorbent assay (ELISA) across different experimental groups. The experimental data were analyzed by Graphpad Prism 9 software. Results: DIA analysis identified 1 850 differential proteins, including 760 up-regulated proteins and 1 090 down-regulated proteins. Weighted correlation network analysis (WGCNA) correlation analysis of phenotypic data such as cell count and CT score with the results of genomics indemnified 575 proteins of MEBrown module which intersected with 35 kinases further screened from 1 850 differential proteins, yielding eight protein kinases: HCK, SYK, PDK2, FGR, PRKCB, ROR1, CAMK1 and GRK6. qPCR showed that the expression of HCK in CRSwNP was significantly higher than that in the control group (P<0.05). Further experiments in mice confirmed that the secretion of IgE, IL-4 and IL-5 in the serum of CRSwNP group was significantly higher than the control group (all P<0.05), indicating successful model establishment. The intervention of HCK significantly decreased the secretion of IgE, IL-4 and IL-5 in serum of mice (all P<0.05). Conclusion: The HCK inhibitor can reduce the inflammatory index of mice with CRSwNP, and HCK is a potential therapeutic target of CRSwNP. 目的: 通过蛋白质组学方法筛选慢性鼻窦炎伴鼻息肉(CRSwNP)的潜在治疗靶点,并通过实验验证其有效性。 方法: 收集自2020年6月至2021年12月于烟台毓璜顶医院耳鼻咽喉头颈外科行手术治疗的患者的鼻黏膜组织样本,其中CRSwNP患者69例,对照组(行上颌窦囊肿切除或视神经减压术)患者39例。通过液相色谱-串联质谱法(liquid chromatography-tandem mass spectrometry,LC-MS/MS)以数据独立采集(data-independent acquisition,DIA)模式分析组织样本,寻找差异表达蛋白,结合生物信息学工具对差异蛋白功能进行分析。并通过实时荧光定量聚合酶链反应(qPCR)及蛋白免疫印迹(WB)技术明确CRSwNP患者鼻组织造血细胞激酶(hematopoietic cell kinase,HCK)表达情况。同时构建CRSwNP小鼠模型并给予HCK抑制剂干预治疗,酶联免疫吸附实验(ELISA)检测不同实验组小鼠血清中炎性因子免疫球蛋白E(IgE)、白细胞介素(IL)-4及IL-5的分泌情况。 结果: 与对照组相比,CRSwNP组鼻黏膜组织筛选出差异蛋白1 850个,其中上调蛋白760个,下调蛋白1 090个。将细胞计数、CT评分等表型数据与组学结果进行加权基因共表达网络分析(weighted correlation network analysis,WGCNA)关联分析,选取MEBrown模块的575个蛋白,与通过蛋白质组学得到的1 850个差异蛋白中进一步筛选出的35个激酶取交集,获得8个蛋白激酶,分别是HCK、SYK、PDK2、FGR、PRKCB、ROR1、CAMK1及GRK6。对差异表达倍数最高的HCK进行实验验证,qPCR及WB结果表明,CRSwNP鼻组织中HCK的表达明显高于对照组(P<0.05)。在动物实验中发现,CRSwNP组小鼠血清中IgE、IL-4及IL-5分泌量较对照组显著升高(P<0.05),而经HCK抑制剂干预后,小鼠血清中IgE、IL-4及IL-5分泌量显著降低(P<0.05)。 结论: HCK抑制剂能够降低CRSwNP小鼠的炎性指标,HCK有望成为CRSwNP的潜在治疗靶点。.
引用
- Li T, Sun CY, Song ZY, et al. [Screening and validation of therapeutic targets for chronic sinusitis with nasal polyps based on proteomics]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024. PMID: 39107122. doi:10.3760/cma.j.cn115330-20240131-00070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。